Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs.
A new study coming out of York University's Centre for Disease Modelling in the Faculty of Science shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other—sometimes "unintuitive"—revelations of how factors like age, sex and comorbidities do and don't affect immune response.
The work is published in the journal Scientific Reports.
